SUPPORT: 48-week results of fosamprenavir/ritonavir vs efavirenz with abacavir/lamivudine in under-represented, antiretroviral-naïve patients

Detalles Bibliográficos
Autores principales: Kumar, P, DeJesus, E, Huhn, G, Sloan, L, Garcia, F, Small, C, Edelstein, H, Felizarta, F, Hao, R, Ha, B, Stancil, B, Ross, L, Oie, K, Pappa, K
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The International AIDS Society 2010
Materias:
Poster Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3113075/
http://dx.doi.org/10.1186/1758-2652-13-S4-P7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3113075/
http://dx.doi.org/10.1186/1758-2652-13-S4-P7

Ejemplares similares